ONEFORTYONE has announced the release of its 2025 Annual Review reflecting a year of disciplined performance and strategic investment.
In 2025 they delivered strong...
A DEDICATED CAR T-cell therapy service will be established to help treat blood cancers.
CAR T-cell therapy is a form of immunotherapy which reprograms a...